MC1791A1 - Association antivirale - Google Patents

Association antivirale

Info

Publication number
MC1791A1
MC1791A1 MC871869A MC1869A MC1791A1 MC 1791 A1 MC1791 A1 MC 1791A1 MC 871869 A MC871869 A MC 871869A MC 1869 A MC1869 A MC 1869A MC 1791 A1 MC1791 A1 MC 1791A1
Authority
MC
Monaco
Prior art keywords
antiviral
association
combinations
nucleoside
inhibitors
Prior art date
Application number
MC871869A
Other languages
English (en)
French (fr)
Inventor
Zimmerman Thomas-Paul
Wolberg Gerald
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1791A1 publication Critical patent/MC1791A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
MC871869A 1986-01-30 1987-01-29 Association antivirale MC1791A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868602346A GB8602346D0 (en) 1986-01-30 1986-01-30 Antiviral combinations

Publications (1)

Publication Number Publication Date
MC1791A1 true MC1791A1 (fr) 1987-10-22

Family

ID=10592262

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871869A MC1791A1 (fr) 1986-01-30 1987-01-29 Association antivirale

Country Status (20)

Country Link
US (1) US4897394A (ko)
EP (1) EP0235931B1 (ko)
JP (1) JPS62195337A (ko)
KR (1) KR870006900A (ko)
AT (1) ATE54414T1 (ko)
AU (1) AU590817B2 (ko)
CA (1) CA1283361C (ko)
DD (1) DD261095A5 (ko)
DE (1) DE3763597D1 (ko)
DK (1) DK46787A (ko)
ES (1) ES2031883T3 (ko)
FI (1) FI870377A (ko)
GB (1) GB8602346D0 (ko)
GR (1) GR3000638T3 (ko)
HU (1) HU198394B (ko)
IL (1) IL81422A0 (ko)
MC (1) MC1791A1 (ko)
PL (1) PL263871A1 (ko)
PT (1) PT84219B (ko)
ZA (1) ZA87667B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
WO1994018979A2 (en) * 1993-02-19 1994-09-01 Southern Research Institute Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
WO1994023723A1 (en) * 1993-04-15 1994-10-27 New York University Adenosine receptor agonists for the promotion of wound healing
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
WO1994026273A1 (en) * 1993-05-12 1994-11-24 Hostetler Karl Y Acyclovir derivatives for topical use
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis
US5872123A (en) * 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
CN105079404A (zh) * 2015-09-07 2015-11-25 夏云强 一种治疗多重耐药菌所致感染性创面的中药外洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR890001487B1 (ko) * 1982-10-14 1989-05-04 더 웰컴 파운데이숀 리미티드 푸린 유도체의 제조방법
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
PT82580B (pt) * 1985-05-15 1989-01-17 Wellcome Found Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
FI870377A0 (fi) 1987-01-29
KR870006900A (ko) 1987-08-13
DD261095A5 (de) 1988-10-19
DK46787D0 (da) 1987-01-29
ZA87667B (en) 1988-09-28
GR3000638T3 (en) 1991-09-27
JPS62195337A (ja) 1987-08-28
EP0235931B1 (en) 1990-07-11
PT84219A (en) 1987-02-01
FI870377A (fi) 1987-07-31
IL81422A0 (en) 1987-08-31
DE3763597D1 (de) 1990-08-16
PT84219B (pt) 1989-07-31
PL263871A1 (en) 1988-05-12
HUT42941A (en) 1987-09-28
AU6813587A (en) 1987-08-06
EP0235931A1 (en) 1987-09-09
AU590817B2 (en) 1989-11-16
ES2031883T3 (es) 1993-01-01
GB8602346D0 (en) 1986-03-05
DK46787A (da) 1987-07-31
HU198394B (en) 1989-10-30
US4897394A (en) 1990-01-30
ATE54414T1 (de) 1990-07-15
CA1283361C (en) 1991-04-23

Similar Documents

Publication Publication Date Title
MC1791A1 (fr) Association antivirale
EP0135713A3 (en) Antiviral combinations
DE3854297D1 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
DK654287D0 (da) Antivirale forbindelser
PT88248A (pt) Processo para a preparacao de composicoes farmaceuticas contendo rnas de cadeia dupla com actividade topica
DK0630368T3 (da) Antivirale nukleosidanaloge
ATE376445T1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid- analoge
EP0334361A3 (en) Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives
DK615788A (da) Nucleosidforbindelser til anvendelse mod virale infektioner
DE68900760D1 (de) Virushemmende nukleosidmischung.
HUP0300219A2 (hu) L-nukleozidokat, L-nukleotidokat és analógjaikat tartalmazó készítmények és alkalmazásuk
ATE72122T1 (de) Antivirale mischungen.
EP1204415A4 (en) ANALOGS OF 5 (E) BROMOVINYLURACILS AND RELATED PYRIMIDINE NUCLEOSIDES AS ANTIVIRAL AGENTS AND METHODS OF USE
FR2621816B1 (fr) Application antivirale des ologonucleotides
KR920019362A (ko) 디데옥시 아데노신 및 아데노신 데아미나제 억제물질을 포함하는, 항-hiv활성을 지닌 치료학적 조성물
ATE86107T1 (de) Arginin- und agmatinderivate zur behandlung von protozoen-infektionen.
FR2406446A1 (fr) Application therapeutique de la (s) et (rs)-9-(2,3-dihydroxypropyl)adenine

Legal Events

Date Code Title Description
YP Annual fee paid